FDA inspection
Roche Molecular Systems, Inc.: FDA inspection ending Jun 12, 2026
FDA inspection 1323692 · No Action Indicated (NAI) · Branchburg, NJ
Key facts
| Inspection ID | 1323692 |
|---|---|
| Firm | Roche Molecular Systems, Inc. |
| FEI number | 2243471 |
| Address | 1080 Us Highway 202 S |
| City | Branchburg |
| State | NJ |
| ZIP | 08876 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Jun 12, 2026 |
| Classification | No Action Indicated (NAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data